The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable buzz within the sector. A shift away from Schedule I status, often regarded as outdated and hindering https://bookmarksden.com/story20908500/cannabinoid-rescheduling-a-growth-catalyst